Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01573273 · ClinicalTrials.gov registry record · NA

Oxytocin in Cocaine Dependence

A NA study, sponsored by Medical University of South Carolina.

Completed
Registry status
NA
Development phase
112
Enrollment target

NCT01573273 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 112 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01573273, a NA study, has completed, sponsored by Medical University of South Carolina.

COMPLETED
Registry status
NA
Development phase
112 participants
Enrollment target

Study Summary

Stress is likely involved in relapse to cocaine use. This project will investigate the role oxytocin may play in the stress response in cocaine-dependent men and women and examine how oxytocin may impact brain activity in individuals exposed to cocaine-related cues.

Interventions

  • DRUG Saline
  • DRUG Oxytocin

Trial Details

FieldValue
Enrollment Target 112 participants
Start Date 2012-10
Est. Completion 2017-12-19
Phase NA

What the Registry Record Tells You About NCT01573273

The ClinicalTrials.gov registry entry for NCT01573273 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.

NCT01573273 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01573273 about?

NCT01573273 is a clinical study titled "Oxytocin in Cocaine Dependence". Stress is likely involved in relapse to cocaine use. This project will investigate the role oxytocin may play in the stress response in cocaine-dependent men and women and examine how oxytocin may impact brain activity in individuals exposed to cocaine-related cues.

What is the current status of trial NCT01573273?

This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2012-10. Estimated completion is 2017-12-19.

What interventions are being tested in trial NCT01573273?

The interventions under investigation include: Saline (DRUG), Oxytocin (DRUG).

Who is sponsoring clinical trial NCT01573273?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.